• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

测定膜联蛋白衍生物-红细胞膜相互作用的结合参数。

Measurement of the binding parameters of annexin derivative-erythrocyte membrane interactions.

机构信息

Department of Nuclear Medicine and Molecular Imaging Center, Chang Gung Memorial Hospital, Chang Gung University School of Medicine, Taoyuan, Taiwan.

出版信息

Anal Biochem. 2010 Nov 1;406(1):70-9. doi: 10.1016/j.ab.2010.06.048. Epub 2010 Jul 1.

DOI:10.1016/j.ab.2010.06.048
PMID:20599633
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2926222/
Abstract

Erythrocyte ghosts prepared from fresh blood expressed phosphatidylserine (PS) on the membrane surfaces in a rather stable fashion. The binding of fluorescein-5-isothiocyanate (FITC)-labeled annexin V (ANV) derivatives to these membranes was studied by titration with proteins and with calcium. Whereas the preaddition of ethylenediaminetetraacetic acid (EDTA) to reaction mixtures totally prevented membrane binding, Ca(2+)-dependent binding was only partially reversed by EDTA treatment, consistent with an initial Ca(2+)-dependent binding that became partially Ca(2+) independent. Data derived from saturation titration with ANV derivatives poorly fit the simple protein-membrane equilibrium binding equation and showed negative cooperativity of binding with increasing membrane occupancy. In contrast, calcium titration at low binding site occupancy resulted in excellent fit into the protein-Ca(2+)-membrane equilibrium binding equation. Calcium titrations of FITC-labeled ANV and ANV-6L15 (a novel ANV-Kunitz protease inhibitor fusion protein) yielded a Hill coefficient of approximately 4 in both cases. The apparent dissociation constant for ANV-6L15 was approximately 4-fold lower than that of ANV at 1.2-2.5mM Ca(2+). We propose that ANV-6L15 may provide improved detection of PS exposed on the membrane surfaces of pathological cells in vitro and in vivo.

摘要

从新鲜血液中制备的红细胞 ghost 以相当稳定的方式在膜表面表达磷脂酰丝氨酸 (PS)。通过用蛋白质和钙滴定研究荧光素 5-异硫氰酸酯 (FITC)标记的 annexin V (ANV)衍生物与这些膜的结合。尽管在反应混合物中预先加入乙二胺四乙酸 (EDTA) 可完全阻止膜结合,但 EDTA 处理仅部分逆转了 Ca(2+)-依赖性结合,与初始 Ca(2+)-依赖性结合变得部分 Ca(2+)-非依赖性一致。源自与 ANV 衍生物的饱和滴定获得的数据与简单的蛋白质-膜平衡结合方程拟合不佳,并显示出结合的负协同性,随着膜占有率的增加而增加。相比之下,在低结合位点占有率下进行钙滴定可使蛋白质-Ca(2+)-膜平衡结合方程得到极好的拟合。FITC 标记的 ANV 和 ANV-6L15(一种新型 ANV-Kunitz 蛋白酶抑制剂融合蛋白)的钙滴定在两种情况下均得出约 4 的希尔系数。在 1.2-2.5mM Ca(2+)下,ANV-6L15 的表观解离常数比 ANV 低约 4 倍。我们提出,ANV-6L15 可能会提高体外和体内病理性细胞膜表面暴露的 PS 的检测灵敏度。

相似文献

1
Measurement of the binding parameters of annexin derivative-erythrocyte membrane interactions.测定膜联蛋白衍生物-红细胞膜相互作用的结合参数。
Anal Biochem. 2010 Nov 1;406(1):70-9. doi: 10.1016/j.ab.2010.06.048. Epub 2010 Jul 1.
2
Investigation of a potential scintigraphic tracer for imaging apoptosis: radioiodinated annexin V-Kunitz protease inhibitor fusion protein.用于细胞凋亡成像的潜在闪烁显像剂的研究:放射性碘化膜联蛋白V-库尼茨蛋白酶抑制剂融合蛋白
J Biomed Biotechnol. 2011;2011:675701. doi: 10.1155/2011/675701. Epub 2011 Apr 27.
3
Bolus injections of novel thrombogenic site-targeted fusion proteins comprising annexin-V and Kunitz protease inhibitors attenuate intimal hyperplasia after balloon angioplasty.推注包含膜联蛋白-V和库尼茨蛋白酶抑制剂的新型血栓形成位点靶向融合蛋白可减轻球囊血管成形术后的内膜增生。
Int J Cardiol. 2017 Aug 1;240:339-346. doi: 10.1016/j.ijcard.2017.03.150. Epub 2017 Apr 6.
4
Novel Injury Site Targeted Fusion Protein Comprising Annexin V and Kunitz Inhibitor Domains Ameliorates Ischemia-Reperfusion Injury and Promotes Survival of Ischemic Rat Abdominal Skin Flaps.包含膜联蛋白V和库尼茨抑制剂结构域的新型损伤部位靶向融合蛋白可改善缺血再灌注损伤并促进缺血大鼠腹部皮瓣存活。
Ann Plast Surg. 2017 Mar;78(3 Suppl 2):S129-S134. doi: 10.1097/SAP.0000000000001018.
5
Fusion proteins comprising annexin V and Kunitz protease inhibitors are highly potent thrombogenic site-directed anticoagulants.包含膜联蛋白V和库尼兹蛋白酶抑制剂的融合蛋白是高效的血栓形成位点定向抗凝剂。
Blood. 2005 May 15;105(10):3902-9. doi: 10.1182/blood-2004-11-4435. Epub 2005 Jan 27.
6
Potent cardioprotection from ischemia-reperfusion injury by a two-domain fusion protein comprising annexin V and Kunitz protease inhibitor.由包含 annexin V 和 Kunitz 蛋白酶抑制剂的两结构域融合蛋白提供的缺血再灌注损伤的有效心脏保护作用。
J Thromb Haemost. 2013 Aug;11(8):1454-63. doi: 10.1111/jth.12314.
7
Measurement of the affinity and cooperativity of annexin V-membrane binding under conditions of low membrane occupancy.在低膜占有率条件下膜联蛋白V与膜结合的亲和力和协同性的测定。
Anal Biochem. 2004 Jun 1;329(1):112-9. doi: 10.1016/j.ab.2004.02.043.
8
Cooperative binding of Annexin A5 to phosphatidylserine on apoptotic cell membranes.膜联蛋白 A5 与凋亡细胞膜上的磷脂酰丝氨酸的协同结合。
Phys Biol. 2013 Dec;10(6):065006. doi: 10.1088/1478-3975/10/6/065006. Epub 2013 Dec 4.
9
Lactadherin binding and phosphatidylserine expression on cell surface-comparison with annexin A5.细胞表面上乳凝集素结合与磷脂酰丝氨酸表达——与膜联蛋白A5的比较
Transl Res. 2006 Jul;148(1):19-25. doi: 10.1016/j.lab.2006.03.006.
10
Membrane modulates affinity for calcium ion to create an apparent cooperative binding response by annexin a5.膜调节了对钙离子的亲和力,通过 annexin a5 产生了一种明显的协同结合反应。
Biophys J. 2013 Jun 4;104(11):2437-47. doi: 10.1016/j.bpj.2013.03.060.

引用本文的文献

1
Ascorbate: a forgotten component in the cytotoxicity of Cu(II) ATCUN peptide complexes.抗坏血酸盐:铜(II)-氨基硫醇铜配合物细胞毒性中被遗忘的成分。
J Biol Inorg Chem. 2024 Dec;29(7-8):801-809. doi: 10.1007/s00775-024-02083-9. Epub 2024 Nov 11.
2
Of membranes and malaria: phospholipid asymmetry in Plasmodium falciparum-infected red blood cells.关于膜与疟疾:感染疟原虫的红细胞中的磷脂不对称性。
Cell Mol Life Sci. 2021 May;78(10):4545-4561. doi: 10.1007/s00018-021-03799-6. Epub 2021 Mar 13.
3
Phospholipid Asymmetry in Biological Membranes: Is the Role of Phosphatidylethanolamine Underappreciated?生物膜中的磷脂不对称性:磷脂酰乙醇胺的作用是否被低估了?
J Membr Biol. 2021 Apr;254(2):127-132. doi: 10.1007/s00232-020-00163-w. Epub 2021 Jan 19.
4
Bolus injections of novel thrombogenic site-targeted fusion proteins comprising annexin-V and Kunitz protease inhibitors attenuate intimal hyperplasia after balloon angioplasty.推注包含膜联蛋白-V和库尼茨蛋白酶抑制剂的新型血栓形成位点靶向融合蛋白可减轻球囊血管成形术后的内膜增生。
Int J Cardiol. 2017 Aug 1;240:339-346. doi: 10.1016/j.ijcard.2017.03.150. Epub 2017 Apr 6.
5
Proteoliposomes with the ability to transport Ca(2+) into the vesicles and hydrolyze phosphosubstrates on their surface.具有将钙离子转运到囊泡中并在其表面水解磷酸底物能力的蛋白脂质体。
Arch Biochem Biophys. 2015 Oct 15;584:79-89. doi: 10.1016/j.abb.2015.08.018. Epub 2015 Aug 29.
6
Quantitative analysis of annexin V-membrane interaction by flow cytometry.通过流式细胞术对膜联蛋白V与膜相互作用进行定量分析。
Eur Biophys J. 2015 Jul;44(5):325-36. doi: 10.1007/s00249-015-1026-9. Epub 2015 Apr 29.
7
Potent cardioprotection from ischemia-reperfusion injury by a two-domain fusion protein comprising annexin V and Kunitz protease inhibitor.由包含 annexin V 和 Kunitz 蛋白酶抑制剂的两结构域融合蛋白提供的缺血再灌注损伤的有效心脏保护作用。
J Thromb Haemost. 2013 Aug;11(8):1454-63. doi: 10.1111/jth.12314.
8
Investigation of a potential scintigraphic tracer for imaging apoptosis: radioiodinated annexin V-Kunitz protease inhibitor fusion protein.用于细胞凋亡成像的潜在闪烁显像剂的研究:放射性碘化膜联蛋白V-库尼茨蛋白酶抑制剂融合蛋白
J Biomed Biotechnol. 2011;2011:675701. doi: 10.1155/2011/675701. Epub 2011 Apr 27.

本文引用的文献

1
The imaging of apoptosis with the radiolabelled annexin A5: a new tool in translational research.放射性标记膜联蛋白A5对细胞凋亡的成像:转化研究中的一种新工具。
Curr Clin Pharmacol. 2006 May;1(2):129-37. doi: 10.2174/157488406776872541.
2
Regulation of phospholipid asymmetry in the erythrocyte membrane.红细胞膜中磷脂不对称性的调节。
Curr Opin Hematol. 2008 May;15(3):191-5. doi: 10.1097/MOH.0b013e3282f97af7.
3
Entropic and enthalpic contributions to annexin V-membrane binding: a comprehensive quantitative model.膜联蛋白V与膜结合的熵和焓贡献:一个综合定量模型。
J Biol Chem. 2008 Mar 7;283(10):6126-35. doi: 10.1074/jbc.M707637200. Epub 2008 Jan 3.
4
Noninvasive imaging of apoptosis in cardiovascular disease.心血管疾病中细胞凋亡的无创成像
Heart Fail Rev. 2008 Jun;13(2):163-73. doi: 10.1007/s10741-007-9068-4.
5
In vitro measurement of cell death with the annexin A5 affinity assay.采用膜联蛋白A5亲和分析法进行细胞死亡的体外测量。
Nat Protoc. 2006;1(1):363-7. doi: 10.1038/nprot.2006.55.
6
Lactadherin binding and phosphatidylserine expression on cell surface-comparison with annexin A5.细胞表面上乳凝集素结合与磷脂酰丝氨酸表达——与膜联蛋白A5的比较
Transl Res. 2006 Jul;148(1):19-25. doi: 10.1016/j.lab.2006.03.006.
7
Reduction of circulating annexin A5 levels and resistance to annexin A5 anticoagulant activity in women with recurrent spontaneous pregnancy losses.复发性自然流产女性循环中膜联蛋白A5水平降低及对膜联蛋白A5抗凝活性产生抵抗
Am J Obstet Gynecol. 2006 Jan;194(1):182-8. doi: 10.1016/j.ajog.2005.05.034.
8
Past, present, and future of annexin A5: from protein discovery to clinical applications.膜联蛋白A5的过去、现在与未来:从蛋白质发现到临床应用
J Nucl Med. 2005 Dec;46(12):2035-50.
9
Surface exposure of phosphatidylserine in pathological cells.病理细胞中磷脂酰丝氨酸的表面暴露。
Cell Mol Life Sci. 2005 May;62(9):971-88. doi: 10.1007/s00018-005-4527-3.
10
The conserved core domains of annexins A1, A2, A5, and B12 can be divided into two groups with different Ca2+-dependent membrane-binding properties.膜联蛋白A1、A2、A5和B12的保守核心结构域可分为两组,具有不同的钙离子依赖性膜结合特性。
Biochemistry. 2005 Mar 1;44(8):2833-44. doi: 10.1021/bi047642+.